Regenerex Pharma changes fiscal year end from March 31 to December 31

REGENEREX PHARMA, INC.

Board approved fiscal year change effective September 22, 2025.
New fiscal year end will be December 31, replacing March 31.
Transition report on Form 10-K for April 1, 2025 to December 31, 2025 to be filed.
No other amendments to bylaws or articles were disclosed.

item 5.03

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

REGENEREX PHARMA, INC.: Changed fiscal year end from March 31 to December 31 (effective 2025-09-22).

Change: fiscal year change
Effective: 2025-09-22

Exact text from the filing

the Board of Directors (the “Board”) of Regenerex Pharma, Inc. (the “Company”) approved a change to the Company’s fiscal year end from March 31 to December 31

View on SEC.gov

Browse all governance changes →

REGENEREX PHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001472375-25-000130

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.